AltimateMedical Announces Partnership with Therafin
Morton, MN – April 4th 2025 – AltimateMedical, a leading designer and manufacturer of innovative medical technology for the complex rehabilitation therapy market, today announces a strategic partnership with Therafin Corporation, a privately held company headquartered in Frankfort, IL. The partnership closed on March 31, 2025. AltimateMedical welcomes President Todd Fink, a member of the company’s founding family, and all Therafin stakeholders into the AltimateMedical and Granite communities.
This partnership combines the strengths of both companies, significantly expanding their collective product offerings and creating opportunities to enhance product innovation and reach a broader market. By joining forces, AltimateMedical and Therafin will provide comprehensive solutions, enhancing value for customers and partners in the complex rehabilitation and healthcare markets.
Therafin President, Todd Fink, expressed enthusiasm about the partnership, stating, “We’re excited to partner with AltimateMedical as we work to offer the best customer support in the business and take our product development to the next level. This collaboration strengthens our commitment to our customers, our team, and the values my father built this company on. We’re proud to continue our legacy of private ownership and look forward to this next phase of growth—together.”
“AltimateMedical and Therafin share a deep commitment to improve lives with thoughtfully designed, innovative medical technology and to enhance stakeholder wellbeing over the long term,” said Ryan Williams, CEO of AltimateMedical. “We warmly welcome Therafin team members, customers, and suppliers into the AltimateMedical family and look forward to our shared future of innovation and collaboration.”
The partnership is effective immediately, with no disruption expected to existing customer or supplier relationships.